Sam Altman, the chief executive of OpenAI, recently invested US$180 million into Retro Biosciences—a company seeking to extend human lifespans by ten healthy years.
This post was originally published on this website.
Sam Altman, the chief executive of OpenAI, recently invested US$180 million into Retro Biosciences—a company seeking to extend human lifespans by ten healthy years.
This post was originally published on this website.
© 2023 TopToronto.ca | The Best of Toronto | Living & Working in the 6ix